Percutaneous Native Renal Biopsy Adequacy: A Successful Interdepartmental Quality Improvement Activity

Background: An adequate renal biopsy is essential for diagnosis and treatment of medical renal disease. Objective: We evaluated two initiatives to improve adequacy of renal biopsy samples at our centre. Design: Retrospective determination of renal biopsy adequacy. Setting: Queen Elizabeth II Health...

Full description

Bibliographic Details
Main Authors: Laurette Geldenhuys, Peter Nicholson, Namita Sinha, Angela Dini, Steve Doucette, Talal Alfaadhel, Valerie Keough, Michael West
Format: Article
Language:English
Published: SAGE Publishing 2015-03-01
Series:Canadian Journal of Kidney Health and Disease
Online Access:https://doi.org/10.1186/s40697-015-0043-z
id doaj-c4c891162f624768be8f96eaf2dc76cc
record_format Article
spelling doaj-c4c891162f624768be8f96eaf2dc76cc2020-11-25T01:27:14ZengSAGE PublishingCanadian Journal of Kidney Health and Disease2054-35812015-03-01210.1186/s40697-015-0043-zPercutaneous Native Renal Biopsy Adequacy: A Successful Interdepartmental Quality Improvement ActivityLaurette Geldenhuys0Peter Nicholson1Namita Sinha2Angela Dini3Steve Doucette4Talal Alfaadhel5Valerie Keough6Michael West7 Department of Pathology and Laboratory Medicine, Dalhousie University, Halifax, Nova Scotia, Canada Department of Pathology and Laboratory Medicine, Dalhousie University, Halifax, Nova Scotia, Canada Department of Pathology and Laboratory Medicine, Dalhousie University, Halifax, Nova Scotia, Canada Department of Pathology and Laboratory Medicine, Dalhousie University, Halifax, Nova Scotia, Canada Department of Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada Department of Diagnostic Imaging, Dalhousie University, Halifax, Nova Scotia, Canada Department of Medicine, Dalhousie University, Halifax, Nova Scotia, CanadaBackground: An adequate renal biopsy is essential for diagnosis and treatment of medical renal disease. Objective: We evaluated two initiatives to improve adequacy of renal biopsy samples at our centre. Design: Retrospective determination of renal biopsy adequacy. Setting: Queen Elizabeth II Health Sciences Centre. Patients: Patients undergoing medical renal biopsies. Measurements: Renal biopsy adequacy. Methods: The first initiative was to restrict the performance of biopsies to a smaller group of radiologists and to include a comment on biopsy adequacy in every pathology report. The second initiative was to introduce on-site adequacy assessment by a medical laboratory technologist. Native renal and allograft biopsy adequacies were calculated for three periods: 1) baseline, October 2005 to September 2006; 2) after implementation of the first initiative, January 2007 to September 2011; and 3) after implementation of the second initiative, October 2011 to September 2012. A subset of native renal biopsies was examined to determine if there was a relationship between adequacy and number of passes. Results: The percentages of adequate native renal biopsies during the first, second, and third periods were 31%, 72% and 90%, respectively. This represents a significant increase (40%, p < 0.0001) in adequacy following the first initiative, and another significant increase (18%, p = 0.0003) following the second initiative. The percentages of adequate renal allograft biopsies during the first, second, and third periods were 75%, 56% and 69%, respectively. These changes in adequacy were not statistically significant. In the subset of native renal biopsies examined, a biopsy comprising more than three cores was not associated with increase in adequacy. Limitations: The most important limitation is the lack of generally accepted and applied adequacy criteria limiting generalizability of our findings. Conclusions: Restricting the performance of biopsies to subspecialist operators, including an adequacy statement in the renal biopsy report and on-site adequacy assessment were effective in significantly improving native renal biopsy adequacy. This improvement appeared unrelated to an increase in the number of passes taken with a biopsy needle. Neither initiative improved the low adequacy of allograft biopsies.https://doi.org/10.1186/s40697-015-0043-z
collection DOAJ
language English
format Article
sources DOAJ
author Laurette Geldenhuys
Peter Nicholson
Namita Sinha
Angela Dini
Steve Doucette
Talal Alfaadhel
Valerie Keough
Michael West
spellingShingle Laurette Geldenhuys
Peter Nicholson
Namita Sinha
Angela Dini
Steve Doucette
Talal Alfaadhel
Valerie Keough
Michael West
Percutaneous Native Renal Biopsy Adequacy: A Successful Interdepartmental Quality Improvement Activity
Canadian Journal of Kidney Health and Disease
author_facet Laurette Geldenhuys
Peter Nicholson
Namita Sinha
Angela Dini
Steve Doucette
Talal Alfaadhel
Valerie Keough
Michael West
author_sort Laurette Geldenhuys
title Percutaneous Native Renal Biopsy Adequacy: A Successful Interdepartmental Quality Improvement Activity
title_short Percutaneous Native Renal Biopsy Adequacy: A Successful Interdepartmental Quality Improvement Activity
title_full Percutaneous Native Renal Biopsy Adequacy: A Successful Interdepartmental Quality Improvement Activity
title_fullStr Percutaneous Native Renal Biopsy Adequacy: A Successful Interdepartmental Quality Improvement Activity
title_full_unstemmed Percutaneous Native Renal Biopsy Adequacy: A Successful Interdepartmental Quality Improvement Activity
title_sort percutaneous native renal biopsy adequacy: a successful interdepartmental quality improvement activity
publisher SAGE Publishing
series Canadian Journal of Kidney Health and Disease
issn 2054-3581
publishDate 2015-03-01
description Background: An adequate renal biopsy is essential for diagnosis and treatment of medical renal disease. Objective: We evaluated two initiatives to improve adequacy of renal biopsy samples at our centre. Design: Retrospective determination of renal biopsy adequacy. Setting: Queen Elizabeth II Health Sciences Centre. Patients: Patients undergoing medical renal biopsies. Measurements: Renal biopsy adequacy. Methods: The first initiative was to restrict the performance of biopsies to a smaller group of radiologists and to include a comment on biopsy adequacy in every pathology report. The second initiative was to introduce on-site adequacy assessment by a medical laboratory technologist. Native renal and allograft biopsy adequacies were calculated for three periods: 1) baseline, October 2005 to September 2006; 2) after implementation of the first initiative, January 2007 to September 2011; and 3) after implementation of the second initiative, October 2011 to September 2012. A subset of native renal biopsies was examined to determine if there was a relationship between adequacy and number of passes. Results: The percentages of adequate native renal biopsies during the first, second, and third periods were 31%, 72% and 90%, respectively. This represents a significant increase (40%, p < 0.0001) in adequacy following the first initiative, and another significant increase (18%, p = 0.0003) following the second initiative. The percentages of adequate renal allograft biopsies during the first, second, and third periods were 75%, 56% and 69%, respectively. These changes in adequacy were not statistically significant. In the subset of native renal biopsies examined, a biopsy comprising more than three cores was not associated with increase in adequacy. Limitations: The most important limitation is the lack of generally accepted and applied adequacy criteria limiting generalizability of our findings. Conclusions: Restricting the performance of biopsies to subspecialist operators, including an adequacy statement in the renal biopsy report and on-site adequacy assessment were effective in significantly improving native renal biopsy adequacy. This improvement appeared unrelated to an increase in the number of passes taken with a biopsy needle. Neither initiative improved the low adequacy of allograft biopsies.
url https://doi.org/10.1186/s40697-015-0043-z
work_keys_str_mv AT laurettegeldenhuys percutaneousnativerenalbiopsyadequacyasuccessfulinterdepartmentalqualityimprovementactivity
AT peternicholson percutaneousnativerenalbiopsyadequacyasuccessfulinterdepartmentalqualityimprovementactivity
AT namitasinha percutaneousnativerenalbiopsyadequacyasuccessfulinterdepartmentalqualityimprovementactivity
AT angeladini percutaneousnativerenalbiopsyadequacyasuccessfulinterdepartmentalqualityimprovementactivity
AT stevedoucette percutaneousnativerenalbiopsyadequacyasuccessfulinterdepartmentalqualityimprovementactivity
AT talalalfaadhel percutaneousnativerenalbiopsyadequacyasuccessfulinterdepartmentalqualityimprovementactivity
AT valeriekeough percutaneousnativerenalbiopsyadequacyasuccessfulinterdepartmentalqualityimprovementactivity
AT michaelwest percutaneousnativerenalbiopsyadequacyasuccessfulinterdepartmentalqualityimprovementactivity
_version_ 1725105884873359360